Crommentuijn, M. H., Kantar, R., Noske, D. P., Vandertop, W. P., Badr, C. E., Würdinger, T., . . . Tannous, B. A. (2016). Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model. Mol Ther Oncolytics.

Crommentuijn, Matheus HW, Rami Kantar, David P. Noske, W Peter Vandertop, Christian E. Badr, Thomas Würdinger, Casey A. Maguire, and Bakhos A. Tannous. "Systemically Administered AAV9-sTRAIL Combats Invasive Glioblastoma in a Patient-derived Orthotopic Xenograft Model." Mol Ther Oncolytics 2016.

Crommentuijn, Matheus HW, et al. "Systemically Administered AAV9-sTRAIL Combats Invasive Glioblastoma in a Patient-derived Orthotopic Xenograft Model." Mol Ther Oncolytics 2016.